

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 7.83666576 |
| 2 | cytidine catabolic process (GO:0006216) | 7.83666576 |
| 3 | cytidine deamination (GO:0009972) | 7.83666576 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.19583740 |
| 5 | DNA deamination (GO:0045006) | 6.87130551 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.85414370 |
| 7 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.07814748 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.71366748 |
| 9 | T cell migration (GO:0072678) | 5.60760466 |
| 10 | positive T cell selection (GO:0043368) | 5.56259635 |
| 11 | positive regulation of calcium-mediated signaling (GO:0050850) | 5.34797400 |
| 12 | negative T cell selection (GO:0043383) | 5.23768751 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 5.22002355 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.52906849 |
| 15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.51696463 |
| 16 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.42002115 |
| 17 | thymic T cell selection (GO:0045061) | 4.40493626 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.33483937 |
| 19 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.29474387 |
| 20 | response to interleukin-15 (GO:0070672) | 4.27758545 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17463204 |
| 22 | regulation of calcium-mediated signaling (GO:0050848) | 4.12217084 |
| 23 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.11204176 |
| 24 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.10403557 |
| 25 | regulation of B cell differentiation (GO:0045577) | 4.10007304 |
| 26 | T cell selection (GO:0045058) | 4.07202130 |
| 27 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.06623962 |
| 28 | negative regulation of B cell apoptotic process (GO:0002903) | 4.04412261 |
| 29 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.97822888 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95569158 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 3.92838408 |
| 32 | eosinophil chemotaxis (GO:0048245) | 3.92212317 |
| 33 | negative regulation of T cell apoptotic process (GO:0070233) | 3.87882497 |
| 34 | negative regulation by host of viral transcription (GO:0043922) | 3.83553670 |
| 35 | lymphocyte chemotaxis (GO:0048247) | 3.72069595 |
| 36 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.64904608 |
| 37 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.63752934 |
| 38 | macrophage chemotaxis (GO:0048246) | 3.59205810 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 3.55605894 |
| 40 | eosinophil migration (GO:0072677) | 3.55467290 |
| 41 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.55286457 |
| 42 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.51662220 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51374728 |
| 44 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.49668129 |
| 45 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.47165454 |
| 46 | autophagic vacuole fusion (GO:0000046) | 3.46186110 |
| 47 | T cell costimulation (GO:0031295) | 3.44195575 |
| 48 | T cell apoptotic process (GO:0070231) | 3.43576240 |
| 49 | lymphocyte costimulation (GO:0031294) | 3.39788877 |
| 50 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.39740135 |
| 51 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.38522321 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.36888495 |
| 53 | deoxyribonucleotide catabolic process (GO:0009264) | 3.35279682 |
| 54 | negative regulation of B cell proliferation (GO:0030889) | 3.33409617 |
| 55 | leukocyte aggregation (GO:0070486) | 3.32749332 |
| 56 | cytolysis (GO:0019835) | 3.32235396 |
| 57 | Peyers patch development (GO:0048541) | 3.30866367 |
| 58 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.30866367 |
| 59 | positive regulation of defense response to virus by host (GO:0002230) | 3.30728446 |
| 60 | deoxyribose phosphate catabolic process (GO:0046386) | 3.29425311 |
| 61 | positive regulation of lymphocyte migration (GO:2000403) | 3.25010791 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.24689725 |
| 63 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.22891693 |
| 64 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.20515330 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 3.19186147 |
| 66 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.18299076 |
| 67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.16832613 |
| 68 | actin nucleation (GO:0045010) | 3.15318375 |
| 69 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.14782317 |
| 70 | lymphocyte migration (GO:0072676) | 3.14152997 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.13306431 |
| 72 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.13306431 |
| 73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12650006 |
| 74 | mannosylation (GO:0097502) | 3.12591924 |
| 75 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.11542750 |
| 76 | regulation of viral genome replication (GO:0045069) | 3.11190373 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07205928 |
| 78 | regulation of activation of Janus kinase activity (GO:0010533) | 3.06795228 |
| 79 | DNA dealkylation (GO:0035510) | 3.03935201 |
| 80 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.01590721 |
| 81 | negative regulation of viral transcription (GO:0032897) | 3.00452446 |
| 82 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.00104211 |
| 83 | T cell receptor signaling pathway (GO:0050852) | 3.00057709 |
| 84 | negative regulation of B cell activation (GO:0050869) | 2.99444031 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97897400 |
| 86 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.97640777 |
| 87 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92986736 |
| 88 | positive regulation of tolerance induction (GO:0002645) | 2.92573252 |
| 89 | purine nucleotide salvage (GO:0032261) | 2.91985490 |
| 90 | response to interferon-beta (GO:0035456) | 2.91496383 |
| 91 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.90571773 |
| 92 | regulation of T cell apoptotic process (GO:0070232) | 2.82957887 |
| 93 | DNA demethylation (GO:0080111) | 2.82452167 |
| 94 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.81651959 |
| 95 | regulation of B cell apoptotic process (GO:0002902) | 2.79693568 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78220965 |
| 97 | interferon-gamma production (GO:0032609) | 2.78039009 |
| 98 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.77852061 |
| 99 | T cell mediated immunity (GO:0002456) | 2.76431990 |
| 100 | organelle membrane fusion (GO:0090174) | 2.75878175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.26055072 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.65723689 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.44018734 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.57157279 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.52082341 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13452552 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.00161822 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.93464255 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73841827 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.71157402 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64309427 |
| 12 | UTX_26944678_Chip-Seq_JUKART_Human | 2.46434737 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45502924 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32449691 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.32390792 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.23107736 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16610807 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11739059 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.5413870 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99258008 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85162968 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 1.80426745 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77845332 |
| 24 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74567808 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68383941 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 1.68069378 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66860798 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.65015966 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.58085402 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56839837 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54952447 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54514605 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52216129 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52041163 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51550918 |
| 36 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48600996 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.46576428 |
| 38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44855322 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42037176 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38350328 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37787707 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32861986 |
| 43 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.26890007 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25798705 |
| 45 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24483570 |
| 46 | P300_27268052_Chip-Seq_Bcells_Human | 1.20274196 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.20158095 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18563227 |
| 49 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15702663 |
| 50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14619196 |
| 51 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14373435 |
| 52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14000838 |
| 53 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09665737 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08838000 |
| 55 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05992672 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05000852 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04348430 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03386110 |
| 59 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03306671 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03254319 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02729782 |
| 62 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02591297 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99901533 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99463343 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96584535 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96390090 |
| 67 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95965846 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 0.95193754 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94463431 |
| 70 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93798842 |
| 71 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92734787 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92455467 |
| 73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90860900 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88477203 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88157576 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87294826 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87261329 |
| 78 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87261329 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 0.87250520 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84284778 |
| 81 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.84012282 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.83883071 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82633552 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82272941 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81006473 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80996849 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80736401 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.80059592 |
| 89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78374561 |
| 90 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.78232883 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.78161336 |
| 92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77980889 |
| 93 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77823095 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77604515 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77511220 |
| 96 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.76577309 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.75596931 |
| 98 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.75219104 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.75166309 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.74912996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.81382227 |
| 2 | MP0009333_abnormal_splenocyte_physiolog | 3.71559856 |
| 3 | MP0009785_altered_susceptibility_to | 3.22550068 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.19250775 |
| 5 | MP0001800_abnormal_humoral_immune | 3.19082361 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.11528059 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.09638699 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.96191204 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.85145321 |
| 10 | MP0002723_abnormal_immune_serum | 2.72054446 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.69911321 |
| 12 | MP0001790_abnormal_immune_system | 2.66450073 |
| 13 | MP0005387_immune_system_phenotype | 2.66450073 |
| 14 | MP0001819_abnormal_immune_cell | 2.63271824 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.62210109 |
| 16 | MP0006082_CNS_inflammation | 2.52810228 |
| 17 | MP0003436_decreased_susceptibility_to | 2.45408352 |
| 18 | MP0005025_abnormal_response_to | 2.45075807 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.42991271 |
| 20 | MP0003866_abnormal_defecation | 2.38547297 |
| 21 | MP0004147_increased_porphyrin_level | 2.31308910 |
| 22 | MP0000685_abnormal_immune_system | 2.27629397 |
| 23 | MP0002398_abnormal_bone_marrow | 2.27335969 |
| 24 | MP0003787_abnormal_imprinting | 2.26223317 |
| 25 | MP0003646_muscle_fatigue | 2.18699273 |
| 26 | MP0003045_fibrosis | 2.13839410 |
| 27 | MP0000716_abnormal_immune_system | 2.07484769 |
| 28 | MP0001873_stomach_inflammation | 2.05925769 |
| 29 | MP0002419_abnormal_innate_immunity | 1.86622629 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.77116264 |
| 31 | MP0002405_respiratory_system_inflammati | 1.76355151 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.73497255 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.72894721 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.66978802 |
| 35 | MP0002429_abnormal_blood_cell | 1.66237420 |
| 36 | MP0002722_abnormal_immune_system | 1.62643708 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.60866662 |
| 38 | MP0005451_abnormal_body_composition | 1.56374779 |
| 39 | MP0002933_joint_inflammation | 1.51396900 |
| 40 | MP0009764_decreased_sensitivity_to | 1.51350332 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.48556686 |
| 42 | MP0003724_increased_susceptibility_to | 1.45903317 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.39606732 |
| 44 | MP0001853_heart_inflammation | 1.39135728 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.37983931 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 1.32945666 |
| 47 | MP0005310_abnormal_salivary_gland | 1.31200812 |
| 48 | MP0002006_tumorigenesis | 1.29699852 |
| 49 | MP0008469_abnormal_protein_level | 1.27852289 |
| 50 | MP0003448_altered_tumor_morphology | 1.23426079 |
| 51 | MP0009763_increased_sensitivity_to | 1.21746268 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.16637594 |
| 53 | MP0003252_abnormal_bile_duct | 1.12570356 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.11784720 |
| 55 | MP0009697_abnormal_copulation | 1.10162179 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.07960950 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.06008330 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.02376677 |
| 59 | MP0004947_skin_inflammation | 0.97273432 |
| 60 | MP0003075_altered_response_to | 0.94467814 |
| 61 | MP0001905_abnormal_dopamine_level | 0.92886595 |
| 62 | MP0002163_abnormal_gland_morphology | 0.91295296 |
| 63 | MP0001968_abnormal_touch/_nociception | 0.90600269 |
| 64 | MP0004381_abnormal_hair_follicle | 0.88911963 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.86239394 |
| 66 | MP0008872_abnormal_physiological_respon | 0.85345538 |
| 67 | MP0002009_preneoplasia | 0.84750565 |
| 68 | MP0009643_abnormal_urine_homeostasis | 0.84268687 |
| 69 | MP0005166_decreased_susceptibility_to | 0.82934091 |
| 70 | MP0008873_increased_physiological_sensi | 0.80849504 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.79310905 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.76738357 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.76738357 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 0.76214651 |
| 75 | MP0001764_abnormal_homeostasis | 0.73365130 |
| 76 | MP0002168_other_aberrant_phenotype | 0.70735106 |
| 77 | MP0009278_abnormal_bone_marrow | 0.63991674 |
| 78 | MP0005646_abnormal_pituitary_gland | 0.63469926 |
| 79 | MP0001919_abnormal_reproductive_system | 0.61763551 |
| 80 | MP0000371_diluted_coat_color | 0.61296366 |
| 81 | MP0003880_abnormal_central_pattern | 0.60117153 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.59194623 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.57886529 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.55937315 |
| 85 | MP0005083_abnormal_biliary_tract | 0.55423992 |
| 86 | MP0005390_skeleton_phenotype | 0.53074787 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.50955026 |
| 88 | MP0003786_premature_aging | 0.49506578 |
| 89 | MP0000858_altered_metastatic_potential | 0.48487286 |
| 90 | MP0001501_abnormal_sleep_pattern | 0.48331879 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48329800 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.48106425 |
| 93 | MP0002095_abnormal_skin_pigmentation | 0.47733928 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.46979756 |
| 95 | MP0008004_abnormal_stomach_pH | 0.46902938 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.45868011 |
| 97 | MP0006292_abnormal_olfactory_placode | 0.45609386 |
| 98 | MP0006276_abnormal_autonomic_nervous | 0.45281080 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.44055604 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.43913180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe combined immunodeficiency (HP:0004430) | 5.99696759 |
| 2 | T lymphocytopenia (HP:0005403) | 5.94788625 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.73663141 |
| 4 | Agammaglobulinemia (HP:0004432) | 5.66668327 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 5.39948481 |
| 6 | Stomatitis (HP:0010280) | 4.86397901 |
| 7 | Combined immunodeficiency (HP:0005387) | 4.70649219 |
| 8 | Aplastic anemia (HP:0001915) | 4.59335920 |
| 9 | Thyroiditis (HP:0100646) | 4.42804617 |
| 10 | Abnormality of T cells (HP:0002843) | 4.41261792 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.37836461 |
| 12 | IgG deficiency (HP:0004315) | 4.30942980 |
| 13 | Recurrent viral infections (HP:0004429) | 4.16913489 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01175840 |
| 15 | Increased IgM level (HP:0003496) | 3.90776727 |
| 16 | Chronic diarrhea (HP:0002028) | 3.85472128 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.82203375 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.82058036 |
| 19 | Hypoproteinemia (HP:0003075) | 3.76468358 |
| 20 | Meningitis (HP:0001287) | 3.74462949 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.62629523 |
| 22 | B lymphocytopenia (HP:0010976) | 3.60814326 |
| 23 | IgM deficiency (HP:0002850) | 3.52377403 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.50086275 |
| 25 | Abnormality of B cell number (HP:0010975) | 3.47826835 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46081323 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46081323 |
| 28 | Abnormality of eosinophils (HP:0001879) | 3.39186339 |
| 29 | Abnormality of the prostate (HP:0008775) | 3.23468278 |
| 30 | Eosinophilia (HP:0001880) | 3.14687158 |
| 31 | Granulocytopenia (HP:0001913) | 3.11896999 |
| 32 | Increased IgE level (HP:0003212) | 3.05090469 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 2.96569185 |
| 34 | Encephalitis (HP:0002383) | 2.94534880 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85594428 |
| 36 | Obstructive lung disease (HP:0006536) | 2.85594428 |
| 37 | Hypoplasia of the thymus (HP:0000778) | 2.82826484 |
| 38 | Leukocytosis (HP:0001974) | 2.77502774 |
| 39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.75033478 |
| 40 | Acute hepatic failure (HP:0006554) | 2.69556867 |
| 41 | Mitochondrial inheritance (HP:0001427) | 2.63293282 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.63215223 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.62107563 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.59992255 |
| 45 | Acute encephalopathy (HP:0006846) | 2.58912395 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57769077 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.57769077 |
| 48 | Recurrent bronchitis (HP:0002837) | 2.51178044 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.47909610 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46841502 |
| 51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.46565283 |
| 52 | Lymphopenia (HP:0001888) | 2.45809965 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.45087999 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42682963 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.40736085 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.37911512 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.34707330 |
| 58 | Joint swelling (HP:0001386) | 2.32269341 |
| 59 | Increased muscle lipid content (HP:0009058) | 2.31853866 |
| 60 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23931551 |
| 61 | Pancytopenia (HP:0001876) | 2.23639737 |
| 62 | Sepsis (HP:0100806) | 2.17412797 |
| 63 | Severe visual impairment (HP:0001141) | 2.15778122 |
| 64 | Skin rash (HP:0000988) | 2.14499515 |
| 65 | Recurrent skin infections (HP:0001581) | 2.14325617 |
| 66 | Lymphoma (HP:0002665) | 2.07408068 |
| 67 | Cerebral edema (HP:0002181) | 2.03254568 |
| 68 | Renal cortical cysts (HP:0000803) | 2.01462183 |
| 69 | Increased CSF lactate (HP:0002490) | 2.01174449 |
| 70 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.00826539 |
| 71 | Neutropenia (HP:0001875) | 2.00766661 |
| 72 | Cellulitis (HP:0100658) | 1.97239022 |
| 73 | Abnormality of the pleura (HP:0002103) | 1.95925162 |
| 74 | Pulmonary infiltrates (HP:0002113) | 1.95219414 |
| 75 | Eczematoid dermatitis (HP:0000976) | 1.93966966 |
| 76 | J-shaped sella turcica (HP:0002680) | 1.93249508 |
| 77 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.92466298 |
| 78 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90801245 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90801245 |
| 80 | Hepatocellular necrosis (HP:0001404) | 1.89850470 |
| 81 | Sensory axonal neuropathy (HP:0003390) | 1.89545832 |
| 82 | IgA deficiency (HP:0002720) | 1.89511707 |
| 83 | Increased hepatocellular lipid droplets (HP:0006565) | 1.89180353 |
| 84 | Myositis (HP:0100614) | 1.88622380 |
| 85 | Renal Fanconi syndrome (HP:0001994) | 1.86723247 |
| 86 | Progressive muscle weakness (HP:0003323) | 1.86622167 |
| 87 | Abnormality of male internal genitalia (HP:0000022) | 1.83627233 |
| 88 | Papilloma (HP:0012740) | 1.83293774 |
| 89 | Verrucae (HP:0200043) | 1.83293774 |
| 90 | Ureteral stenosis (HP:0000071) | 1.82980124 |
| 91 | Chest pain (HP:0100749) | 1.82279953 |
| 92 | Hepatic necrosis (HP:0002605) | 1.81363500 |
| 93 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80912626 |
| 94 | Abnormality of dental color (HP:0011073) | 1.78959126 |
| 95 | Increased serum ferritin (HP:0003281) | 1.78388369 |
| 96 | Vasculitis (HP:0002633) | 1.76228743 |
| 97 | Recurrent abscess formation (HP:0002722) | 1.75789593 |
| 98 | Chronic sinusitis (HP:0011109) | 1.75688762 |
| 99 | Ureteral obstruction (HP:0006000) | 1.69941484 |
| 100 | Mesangial abnormality (HP:0001966) | 1.68663128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.47134506 |
| 2 | KDR | 5.67603919 |
| 3 | TESK2 | 4.66210097 |
| 4 | VRK2 | 3.74568619 |
| 5 | MAP4K1 | 3.73070554 |
| 6 | TAOK3 | 3.19628911 |
| 7 | ITK | 2.83060647 |
| 8 | PIK3CA | 2.16253299 |
| 9 | SCYL2 | 2.13632320 |
| 10 | TEC | 2.05483863 |
| 11 | MAP3K11 | 1.97957097 |
| 12 | MAP4K2 | 1.95063214 |
| 13 | BCKDK | 1.89972730 |
| 14 | KIT | 1.89192379 |
| 15 | MATK | 1.81543824 |
| 16 | SYK | 1.75503560 |
| 17 | TESK1 | 1.69755747 |
| 18 | LRRK2 | 1.67393459 |
| 19 | BTK | 1.54328889 |
| 20 | ADRBK2 | 1.48858755 |
| 21 | NUAK1 | 1.41678936 |
| 22 | JAK3 | 1.33423991 |
| 23 | MAPK11 | 1.28922049 |
| 24 | PRKCQ | 1.28871209 |
| 25 | GRK1 | 1.22671035 |
| 26 | FES | 1.22200452 |
| 27 | VRK1 | 1.19980197 |
| 28 | ERN1 | 1.17411013 |
| 29 | MAP3K10 | 1.15410592 |
| 30 | LYN | 1.14447527 |
| 31 | NME2 | 1.14044460 |
| 32 | LCK | 1.11768790 |
| 33 | CSK | 1.09065337 |
| 34 | GRK6 | 1.06905864 |
| 35 | TBK1 | 1.04104843 |
| 36 | MAPK13 | 1.00975670 |
| 37 | BMPR2 | 0.99831467 |
| 38 | LIMK1 | 0.96796853 |
| 39 | PIM2 | 0.93782232 |
| 40 | CSF1R | 0.91608909 |
| 41 | RIPK4 | 0.85297151 |
| 42 | TNK2 | 0.83250713 |
| 43 | CCNB1 | 0.81684349 |
| 44 | IKBKB | 0.81319647 |
| 45 | PINK1 | 0.81313939 |
| 46 | SIK2 | 0.78967951 |
| 47 | IKBKE | 0.73320592 |
| 48 | CAMKK2 | 0.70692042 |
| 49 | MARK3 | 0.70542093 |
| 50 | BUB1 | 0.68534221 |
| 51 | NTRK1 | 0.67718666 |
| 52 | GRK7 | 0.67578799 |
| 53 | HCK | 0.67036541 |
| 54 | PLK4 | 0.65512932 |
| 55 | IRAK2 | 0.63000647 |
| 56 | ZAP70 | 0.61888820 |
| 57 | CDK19 | 0.60559686 |
| 58 | TIE1 | 0.58181421 |
| 59 | PIM1 | 0.58018051 |
| 60 | DAPK1 | 0.55271754 |
| 61 | TYK2 | 0.53598670 |
| 62 | FYN | 0.53329869 |
| 63 | MAP3K12 | 0.52855436 |
| 64 | BLK | 0.49125643 |
| 65 | NME1 | 0.48976090 |
| 66 | CAMKK1 | 0.48856272 |
| 67 | INSRR | 0.45426096 |
| 68 | IRAK1 | 0.45386953 |
| 69 | PIK3CG | 0.45121716 |
| 70 | ZAK | 0.42008384 |
| 71 | MYLK | 0.41011112 |
| 72 | IGF1R | 0.39908290 |
| 73 | BMX | 0.39165448 |
| 74 | BCR | 0.36445775 |
| 75 | MAPKAPK5 | 0.35630455 |
| 76 | IRAK4 | 0.35628084 |
| 77 | MAPK12 | 0.35579536 |
| 78 | ADRBK1 | 0.35108027 |
| 79 | CDK9 | 0.32933550 |
| 80 | NEK9 | 0.32929841 |
| 81 | MAP3K14 | 0.30005794 |
| 82 | RPS6KA5 | 0.29572335 |
| 83 | OBSCN | 0.28229150 |
| 84 | PRKCA | 0.27697589 |
| 85 | CDK8 | 0.25962030 |
| 86 | MAPK15 | 0.24978237 |
| 87 | PRKCH | 0.24356056 |
| 88 | GRK5 | 0.24082766 |
| 89 | TAOK2 | 0.23756268 |
| 90 | ERBB2 | 0.23533498 |
| 91 | ATR | 0.22421485 |
| 92 | INSR | 0.22272084 |
| 93 | PRKD1 | 0.20900986 |
| 94 | WNK4 | 0.20595566 |
| 95 | MAPK3 | 0.20412973 |
| 96 | JAK2 | 0.20225253 |
| 97 | FRK | 0.20187225 |
| 98 | MAPKAPK2 | 0.19566037 |
| 99 | CSNK1A1 | 0.19204760 |
| 100 | SRC | 0.19128531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.09935868 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.66327239 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.62327719 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.40930312 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.06387399 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.90329092 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66758121 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.59624667 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.50878731 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.32879866 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.11816568 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.96240800 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94423568 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.88344449 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87977746 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.82488184 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76499473 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.72648058 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69655715 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.57146789 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55463403 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48050152 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.45845562 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40960242 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36918383 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.31832416 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.29666634 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17276432 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10400225 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.09208209 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07722220 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.04602753 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01473518 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01409636 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94743400 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93604746 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 0.93499335 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91968058 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89529665 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78951100 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77203620 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72456910 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72150713 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71296936 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.71056037 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70520734 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69692709 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69589896 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69181939 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67020157 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.66847432 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66229376 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.64520061 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63524598 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61008764 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59990603 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59002933 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57106073 |
| 59 | Protein export_Homo sapiens_hsa03060 | 0.55920369 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55462200 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53956361 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.50918561 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50890986 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.48930464 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.48257391 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47513363 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.46202754 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45349096 |
| 69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43967335 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42957194 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42001952 |
| 72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41148220 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40559065 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.40051845 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39981131 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.39748127 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38277789 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38235614 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37483586 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37273557 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35599775 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33136758 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32878089 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32737183 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32139297 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31767135 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.31656384 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30670443 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29047065 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.28896117 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27592862 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27191406 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26882600 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24943099 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.24739070 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24467083 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23578721 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.23297647 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.20542984 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.18269453 |

